Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Obseva
.
Show all posts
Showing posts with label
Obseva
.
Show all posts
Monday, December 20, 2021
Obseva Announces U.S. FDA Acceptance of New Drug Application for Linzagolix
›
Obseva SA announced the New Drug Application (NDA) for linzagolix for the management of heavy menstrual bleeding associated with uterine...
›
Home
View web version
